NEW YORK (GenomeWeb News) – Contract research organization Covance today announced a collaboration between its genomics laboratory in Seattle and the Institute for Systems Biology to further research into brain tumor biology.
Specifically, Covance's expertise in genomics assays and ISB's expertise in complex genomic networks will be leveraged to unravel the regulation of gene expression in glioblastoma multiforme.
The partners will perform next-generation sequencing to generate datasets, which will be used by researchers to investigate tumor heterogeneity and to find targets for patient stratification and/or therapeutics, Covance said. The goal is to provide a high-quality map of gene expression and RNA structure to enable research into brain tumor biology, it added.
Financial and other terms of the deal were not disclosed.
"The ability to resolve complex regulatory networks requires reproducible, high-quality data," Lee Hood, president of ISB, said in a statement. "We know Covance's experience in genomics and next-generation sequencing will give us an unprecedented level of high-quality data."